Martin Reck

2 ta ish

LungenClinic Grosshansdorf

1. Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer

   Julie R. Brahmer, Karen L. Reckamp, Paul Baas +22

   MaqolaOAOchiq kirish20153 iqtibos

   ABIABI:AkademIndex/2026.other.170111

2. Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer

   Martin Reck, Delvys Rodríguez‐Abreu, Andrew Robinson +15

   MaqolaOAOchiq kirish20162 iqtibos

   ABIABI:AkademIndex/2026.other.170118